Fractyl Health, Inc. Common Stock Form 4 Change in insider ownership

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

General Catalyst GP V, LLC

(Last)

(First)

(Middle)

20 UNIVERSITY ROAD, SUITE 450

(Street)

CAMBRIDGE

02138

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Fractyl Health, Inc. [ GUTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/06/2024		C		4,702,161	A	⁽¹⁾	4,784,323	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Common Stock	02/06/2024		C		98,149	A	⁽¹⁾	99,863	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Preferred Stock	⁽¹⁾	02/06/2024		C			3,204,832	⁽¹⁾	⁽¹⁾	Common Stock	1,493,397	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series A Preferred Stock	⁽¹⁾	02/06/2024		C			66,897	⁽¹⁾	⁽¹⁾	Common Stock	31,172	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾
Series B Preferred Stock	⁽¹⁾	02/06/2024		C			3,098,678	⁽¹⁾	⁽¹⁾	Common Stock	1,443,931	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series B Preferred Stock	⁽¹⁾	02/06/2024		C			64,681	⁽¹⁾	⁽¹⁾	Common Stock	30,140	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾
Series C-1 Preferred Stock	⁽¹⁾	02/06/2024		C			1,314,484	⁽¹⁾	⁽¹⁾	Common Stock	612,527	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series C-1 Preferred Stock	⁽¹⁾	02/06/2024		C			27,438	⁽¹⁾	⁽¹⁾	Common Stock	12,785	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾
Series C-2 Preferred Stock	⁽¹⁾	02/06/2024		C			1,337,665	⁽¹⁾	⁽¹⁾	Common Stock	623,329	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series C-2 Preferred Stock	⁽¹⁾	02/06/2024		C			27,922	⁽¹⁾	⁽¹⁾	Common Stock	13,011	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾
Series D Preferred Stock	⁽¹⁾	02/06/2024		C			906,815	⁽¹⁾	⁽¹⁾	Common Stock	422,560	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series D Preferred Stock	⁽¹⁾	02/06/2024		C			18,929	⁽¹⁾	⁽¹⁾	Common Stock	8,820	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾
Series E Preferred Stock	⁽¹⁾	02/06/2024		C			228,371	⁽¹⁾	⁽¹⁾	Common Stock	106,417	⁽¹⁾	0	I	Directly held by General Catalyst Group V, L.P.⁽²⁾
Series E Preferred Stock	⁽¹⁾	02/06/2024		C			4,767	⁽¹⁾	⁽¹⁾	Common Stock	2,221	⁽¹⁾	0	I	Directly held by GC Entrepreneurs Fund V, L.P.⁽²⁾

1. Name and Address of Reporting Person^*

General Catalyst GP V, LLC

(Last)

(First)

(Middle)

20 UNIVERSITY ROAD, SUITE 450

(Street)

CAMBRIDGE

02138

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

General Catalyst Partners V, L.P.

(Last)

(First)

(Middle)

20 UNIVERSITY ROAD, SUITE 450

(Street)

CAMBRIDGE

02138

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

General Catalyst Group V LP

(Last)

(First)

(Middle)

20 UNIVERSITY ROAD, SUITE 450

(Street)

CAMBRIDGE

02138

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

GC Entrepreneurs Fund V, LP

(Last)

(First)

(Middle)

20 UNIVERSITY ROAD, SUITE 450

(Street)

CAMBRIDGE

02138

(City)

(State)

(Zip)

Explanation of Responses:

1. In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.

2. General Catalyst GP V, LLC ("GCGPV") is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. ("GCGV") and GC Entrepreneurs Fund V, L.P. ("GCEV"). GCGPV is controlled by a group of three or more individuals, or the Managing Directors, having shared voting and dispositive control over the shares held by GCGV and GCEV. Each of the Managing Directors disclaims beneficial ownership of the securities held by GCGV and GCEV except to the extent of his or her pecuniary interest therein, if any.

	General Catalyst GP V, LLC By: Lisa A. Davidson, Attorney-in-fact	02/08/2024
	General Catalyst Partners V, L.P. By: General Catalyst GP V, LLC, its general partner By: Lisa A. Davidson, Attorney-in-fact	02/08/2024
	General Catalyst Group V, L.P. By: General Catalyst Partners V, L.P., its general partner By: General Catalyst GP V, LLC, its general partner By: Lisa A. Davidson, Attorney-in-fact	02/08/2024
	GC Entrepreneurs Fund V, L.P. By: General Catalyst Partners V, L.P., its general partner By: General Catalyst GP V, LLC, its general partner By: Lisa A. Davidson, Attorney-in-fact	02/08/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Fractyl Health, Inc. Common Stock (GUTS) Form 4Change in insider ownership